220 related articles for article (PubMed ID: 16311252)
21. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
22. Intra-allelic mutation at human telomeres.
Britt-Compton B; Baird DM
Biochem Soc Trans; 2006 Aug; 34(Pt 4):581-2. PubMed ID: 16856866
[TBL] [Abstract][Full Text] [Related]
23. Telomere lengths in human pronuclei, oocytes and spermatozoa.
Turner S; Hartshorne GM
Mol Hum Reprod; 2013 Aug; 19(8):510-8. PubMed ID: 23519357
[TBL] [Abstract][Full Text] [Related]
24. Genomic imbalances in key ion channel genes and telomere shortening in sudden cardiac death victims.
Banerjee B; Peiris DN; Koo SH; Chui P; Lee EJ; Hande MP
Cytogenet Genome Res; 2008; 122(3-4):350-5. PubMed ID: 19188705
[TBL] [Abstract][Full Text] [Related]
25. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age.
Trkova M; Prochazkova K; Krutilkova V; Sumerauer D; Sedlacek Z
Cancer; 2007 Aug; 110(3):694-702. PubMed ID: 17567834
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of telomeres in human cancer.
Vera E; Canela A; Fraga MF; Esteller M; Blasco MA
Oncogene; 2008 Nov; 27(54):6817-33. PubMed ID: 18762811
[TBL] [Abstract][Full Text] [Related]
27. Telomere length maintenance--an ALTernative mechanism.
Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
[TBL] [Abstract][Full Text] [Related]
28. Telomerase- and capping-independent yeast survivors with alternate telomere states.
Larrivée M; Wellinger RJ
Nat Cell Biol; 2006 Jul; 8(7):741-7. PubMed ID: 16767083
[TBL] [Abstract][Full Text] [Related]
29. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
[TBL] [Abstract][Full Text] [Related]
30. Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.
Cerone MA; Londoño-Vallejo JA; Autexier C
Oncogene; 2006 Nov; 25(56):7411-20. PubMed ID: 16767163
[TBL] [Abstract][Full Text] [Related]
31. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
32. Chromosome end protection plasticity revealed by Stn1p and Ten1p bypass of Cdc13p.
Petreaca RC; Chiu HC; Eckelhoefer HA; Chuang C; Xu L; Nugent CI
Nat Cell Biol; 2006 Jul; 8(7):748-55. PubMed ID: 16767082
[TBL] [Abstract][Full Text] [Related]
33. Telomeres and telomerase in cancer stem cells.
Ju Z; Rudolph KL
Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
[TBL] [Abstract][Full Text] [Related]
34. Protection against chromosome degradation at the telomeres.
Grandin N; Charbonneau M
Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
[TBL] [Abstract][Full Text] [Related]
35. Ancestral telomere shortening: a countdown that will increase mean life span?
Hertzog RG
Med Hypotheses; 2006; 67(1):157-60. PubMed ID: 16530337
[TBL] [Abstract][Full Text] [Related]
36. Strain-specific telomere length revealed by single telomere length analysis in Caenorhabditis elegans.
Cheung I; Schertzer M; Baross A; Rose AM; Lansdorp PM; Baird DM
Nucleic Acids Res; 2004; 32(11):3383-91. PubMed ID: 15247331
[TBL] [Abstract][Full Text] [Related]
37. Telomeric 3'-overhang length is associated with the size of telomeres.
Rahman R; Forsyth NR; Cui W
Exp Gerontol; 2008 Apr; 43(4):258-65. PubMed ID: 18280685
[TBL] [Abstract][Full Text] [Related]
38. The pattern of chromosome-specific variations in telomere length in humans shows signs of heritability and is maintained through life.
Graakjaer J; Londono-Vallejo JA; Christensen K; Kølvraa S
Ann N Y Acad Sci; 2006 May; 1067():311-6. PubMed ID: 16804004
[TBL] [Abstract][Full Text] [Related]
39. Use of telomerase to create bioengineered tissues.
Shay JW; Wright WE
Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
